It was reported that his left ventricular (lv) lead exhibited oversenslng due to lead placement lv issues lvpp and doesn't pace when oversees the signal only rv paces lead to pacing inhibition.The patient underwent additional testing and the physician noted that the over detection occurred during there respiratory movements of the sternum.At this time, the lead remains in service.No adverse patient effects were reported.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|